Factor V Leiden: Difference between revisions
Elcatracho (talk | contribs) |
Elcatracho (talk | contribs) |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 11: | Line 11: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{Increased clotting DDX}} | |||
==Evaluation== | ==Evaluation== | ||
| Line 33: | Line 33: | ||
<references/> | <references/> | ||
[Category: | [[Category:Heme/Onc]] | ||
Latest revision as of 05:15, 25 January 2021
Background
- Also known as Factor V Leiden Deficiency or FVL
- Point mutation in FV making it resistant to cleavage by activated protein C
- Increased risk of thrombosis
- Most individuals with FVL will never have a venous thromboembolism (VTE)
Clinical Features
- Family history of thrombophilia
- VTE at a young age
- VTE in an atypical location